发明名称 METHODS FOR TREATING RELAPSING FORMS OF MULTIPLE SCLEROSIS
摘要 Disclosed herein are anti-RGMa antibodies and methods of using these antibodies to treat multiple sclerosis, including relapsing forms of multiple sclerosis such as relapsing-remitting multiple sclerosis or relapsing-secondary progressive multiple sclerosis.
申请公布号 US2017073420(A1) 申请公布日期 2017.03.16
申请号 US201615261633 申请日期 2016.09.09
申请人 AbbVie Inc. ;AbbVie Deutschland GmbH & Co. KG 发明人 Greenberg Steven J.;Mueller Bernhard K.;Popp Andreas;Rosebraugh Matthew R.;Haig George M.;Lin Shao-Lee
分类号 C07K16/28;A61K45/06;A61K39/395 主分类号 C07K16/28
代理机构 代理人
主权项 1. A method of treating a relapsing form of multiple sclerosis in a subject in need thereof, the method comprising administering a therapeutically effective amount of an antibody or antigen-binding fragment thereof that specifically binds Repulsive Guidance Molecule A (RGMa), wherein the antibody or antigen binding fragment comprises (a) a variable heavy chain comprising a complementarity determining region (CDR)-1 comprising an amino acid sequence of SEQ ID NO:2, a CDR-2 comprising an amino acid sequence of SEQ ID NO:3, and a CDR-3 comprising an amino acid sequence of SEQ ID NO:4; and (b) a variable light chain comprising a CDR-1 comprising an amino acid sequence of SEQ ID NO:6, a CDR-2 comprising an amino acid sequence of SEQ ID NO:7, and a CDR-3 comprising an amino acid sequence of SEQ ID NO:8.
地址 North Chicago IL US